Copyright
©2013 Baishideng Publishing Group Co.
World J Cardiol. Jan 26, 2013; 5(1): 1-7
Published online Jan 26, 2013. doi: 10.4330/wjc.v5.i1.1
Published online Jan 26, 2013. doi: 10.4330/wjc.v5.i1.1
Table 1 Patients’ characteristics (mean ± SD) n (%)
| NonVSA group | VSA group | P value | |
| (n = 36) | (n = 36) | ||
| Age (yr) | 60 ± 9 | 59 ± 9 | NS |
| Male/female | 31/5 | 30/6 | NS |
| Body mass index (kg/m2) | 25.2 ± 3.2 | 23.2 ± 2.6 | 0.0045 |
| Coronary risk facto | |||
| Smoking | 25 (69) | 24 (67) | NS |
| Current/passt smoker | 11/13 | 12/13 | NS |
| Hypertension | 21 (58) | 19 (53) | NS |
| Dyslipidemia | 11 (31) | 11 (31) | NS |
| Diabetes mellitus | 9 (25) | 4 (11) | NS |
| Taking statins (%) | 4 (11) | 3 (9) | NS |
| LVEF on echocardiography (%) | 71 ± 8 | 68 ± 7 | NS |
- Citation: Teragawa H, Mitsuba N, Ishibashi K, Nishioka K, Kurisu S, Kihara Y. Evaluation of coronary microvascular function in patients with vasospastic angina. World J Cardiol 2013; 5(1): 1-7
- URL: https://www.wjgnet.com/1949-8462/full/v5/i1/1.htm
- DOI: https://dx.doi.org/10.4330/wjc.v5.i1.1